How leading spine centers are refining and increasingly combining these surgical advancements in pursuit of better patient outcomes and care value.
The FDA just approved the first device that uses facet joint replacement to treat degenerative spondylolisthesis with lumbar spinal stenosis. We profile initial results from the trial supporting approval.
Can a shift from 10 vendors of nonspecialized spinal implants to a single vendor reduce procurement costs without compromising care quality? Our findings put conventional wisdom to the test.
There’s no arguing that rhBMP-2 forms bone. The latest research aims to learn whether its adverse effects outweigh its benefits, and in which types of spine fusion procedures the risk-benefit ratio is most favorable.